🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the abuse potential of lorcaserin ...
Status
Completed
Location
Kendle Early Phase, Toronto
Start Date
2008-12
Trial ID
NCT00828659
A randomized, double-blind, placebo-controlled, single-dose, dose escalatio...
Status
Completed
Location
Seoul National University Hospital
Start Date
2013-06
Trial ID
NCT01880502
Treatments Being Tested
This study plans to compare the efficacy of the nicotine patch / lorcaserin...
Status
Completed
Location
Duke Center for Smoking Cessation
Start Date
2016-11-08
Trial ID
NCT02906644
Treatments Being Tested
Purpose: The purpose of this study is to test new pharmacologic strategies ...
Status
Terminated
Location
Augusta University
Start Date
2016-09
Trial ID
NCT02796144
Treatments Being Tested
The purpose of this study is to evaluate the PK properties in fed and faste...
Status
Completed
Location
CRI Worldwide
Start Date
2008-11
Trial ID
NCT00828724
Treatments Being Tested
This phase I trial studies how well lorcaserin works in treating chemothera...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-11-01
Trial ID
NCT04205071
Treatments Being Tested
This is a randomized, cross-over, single-blind, placebo-controlled, single-...
Status
Unknown
Location
Kansas City VA Medical Center
Start Date
2015-11
Trial ID
NCT02680288
Treatments Being Tested
This is a research study of an investigational drug, APD356, a novel, selec...
Status
Completed
Location
Pennington Biomedical Research Center
Start Date
2005-06
Trial ID
NCT00116740
Treatments Being Tested
In smokers who are motivated to stop smoking, treatment with lorcaserin com...
Status
Completed
Location
Pharmacology Research Institute
Start Date
2014-03
Trial ID
NCT02044874
Treatments Being Tested
The fixed-dose combination of naltrexone 8mg and bupropion 90mg extended-re...
Status
Completed
Location
Currax Pharmaceuticals
Start Date
2014-09
Trial ID
NCT06090461